Target intelligence / Profile preview

Stool softener

Molecular classification
Anionic surfactant, Pharmacological class
01

Overview

Stool softeners, also known as emollient laxatives, represent a pharmacological class of medications rather than a specific biological target, receptor, or enzyme. These agents, most commonly represented by docusate sodium or docusate calcium, function through their physical-chemical properties as anionic surfactants. By lowering the surface tension at the oil-water interface of the stool, they facilitate the penetration of water and lipids into the fecal mass, resulting in a softer consistency that is easier to pass. Stool softeners are primarily used to treat and prevent mild constipation and are particularly beneficial for patients who must avoid straining during defecation, such as those recovering from myocardial infarction, abdominal surgery, or childbirth. Because they act locally within the intestinal lumen through surfactant activity and do not bind to specific proteins or cellular receptors to exert their primary effect, they are considered a therapeutic class rather than a molecular target.

Other names
Emollient laxativeSurfactant laxativeDocusate sodiumDocusate calciumDioctyl sulfosuccinate
02

Mechanism of action

Acts as an anionic surfactant to lower the surface tension at the oil-water interface of the stool, allowing water and lipids to penetrate and soften the fecal mass.

03

Biological functions

Fecal softeningReduction of fecal surface tensionLubrication of the intestinal tract
04

Disease associations

ConstipationHemorrhoidsAnal fissuresPost-operative recoveryMyocardial infarction (prophylaxis against straining)
05

Safety considerations

Electrolyte imbalanceAbdominal crampingThroat irritation (liquid formulations)Increased systemic absorption of co-administered mineral oil
06

Interacting drugs

Docusate sodium

4 more in the full profile.

07

Biomarkers

Bristol Stool ScaleBowel movement frequencyStool consistency

Beyond the preview

Go deeper on Stool softener.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stool softener.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call